254
1. Sakata LM, Deleon-Ortega J, Sakata V, Girkin CA. Optical
Coherence Tomography od the retina and the Optic Nerve. Clin
Experiment Ophthalmol 2009;37:90-99
2. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of
neovascular age-related macular degeneration: applying clinical trial
results to the treatment of everyday patients. Am J Ophthalmol 2007;
144: 627–37
3. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence
tomography identification of occult choroidal neovascularization in
age-related macular degeneration. Am J Ophthalmol. 2007;144:592–
599
4. Pieroni CG, Witkin AJ, Ko TH, et al. Ultrahigh resolution optical
coherence tomography in non-exudative age related macular
degeneration. Br J Ophthalmol 2006;90:191–197.
5. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases
with optical coherence tomography. Ophthalmology 1995;102:217–
229
6. Brancato R, Tremoloada G. Tomografia óptica de coherencia en la
degeneración macular asociada a la edad . En: Monés J, Gómez-Ulla
F. Degeneración macular asociada a la edad. Proas Science 2005, 73-
84
7. Criado Muñoz P. Tomografía de Coherencia Óptica en el estudio de
la patología macular. Boletín de la Sociedad Oftalmologica de Madrid
- N.º 48 2008
8. España Contreras M, Fernández-Baca Casares I. OCT en las
enfermedades retinianas y del nervio óptico. E.U.R.O.M.E.D.I.C.E.,
Ediciones Médicas, S. L. 2007;15-30
9. Schmidt-Erfurth U, Leitgeb RA, Michels S, et al. Three-dimensional
ultrahigh-resolution optical coherence tomography of macular
diseases. Invest Ophthalmol Vis Sci 2005;46:3393–3402
10. Sunness JS, Margalit E, Srikumaran D et als. The long-term natural
history of geographic atrophy from age-related macular degeneration:
enlargement of atrophy and implications for interventional clinical
trials. Ophthalmology 2007;114:271–277
11. Chen TC, Cense B, Miller JW, et al. Histologic correlation of in
vivo optical coherence tomography images of the human retina.Am J
Ophthalmol 2006;141:1165–8
12. Age-Related Eye Disease Study Research Group, The Age-Related Eye
Disease Study system for classifying age-related macular degeneration
from stereoscopic color fundus photographs: the Age-Related Eye
Disease Study report nº 6. Am J Ophthalmol 2001;132:668–681.
13. Hageman GS, Luthert PJ, Chong NH et als. An integrated
hypothesis that considers drusen as biomarkers of immune-
mediated processes at the RPE-Bruch’s membrane interface in
aging and age-related macular degeneration. Prog Retin Eye Res
2001;20:705-732
14. Yi K, Mujat M, Park BH, Sun W, Miller JW, Seddon JM, Young
LH, de Boer JF, Chen TC. Spectral Domain Optical Coherence
Tomography for quantitative evaluation of drusen and associated
structural changes in non-neovascular age-related macular
degeneration. Br J Ophthalmol 2009;93:176-81
15. Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure
imaging with spectral domain optical coherence tomography in age-
related macular degeneration. Ophthalmology 2008;115:1883-90
16. Sandhu SS, Talks SJ. Correlation of optical coherence tomography,
with or without additional colour fundus photography, with stereo
fundus fluorescein angiography in diagnosing choroidal neovascular
membranes. Br J Ophthalmol 2005;89:967–970
17. Bearelly S, Chau FY, Koreishi A, Stinnett SS, Izatt JA, Toth CA.
Spectral domain optical coherence tomography imaging of geographic
atrophy margins. Ophthalmology 2009;116(9):1762-9
18. Klein R, Klein BE, Knudtson MD, et als. Fifteen-year cumulative
incidence of age-related macular degeneration: the Beaver Dam Eye
Study. Ophthalmology 2007;114:253–62.
19. Liakopoulos S, Ongchin S, Bansal A, Msutta S, Walsh AC, Updike
PG, Sadda SR. Quantitative Optical Coherence Tomography findings
in varios subtypes of Neovascular Age-related Macular Degeneration.
Invest Ophthalmol Vis Sci 2008;49:5048-54
20. Hughes EH, Khan J, Patel N, Kashani S, Chong NV. In vivo
demonstration of the anatomic differences between classic and occult
choroidal neovascularization using optical coherence tomography. Am
J Ophthalmol 2005;139:344–346.
21. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence
tomography of age-related macular degeneration and choroidal
neovascularization. Ophthalmology 1996;103:1260–1270
22. Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh
AC, Sadda SR. Relationship between optical coherence tomography
retinal parameters and visual acuity in neovascular age-related macular
degeneration. Ophthalmology 2008;115:2206-14
23. Sadda SR, Liakopoulos S, Keane PA, Ongchin SC, Msutta S, Chang
KT, Walsh AC. Relationship between angiographic and optical
coherence tomographic (OCT) parameters for quantifying choroidal
neovascular lesions. Graefes Arch Clin Exp Ophthalmol 2009; E-Pub
24. Iijima H, Iida T, Imai M, Gohdo T, Tsukahara S. Optical coherence
tomography of orange-red subretinal lesions in eyes with idiopathic
polypoidal choroidal vasculopathy. Am J Ophthalmol 2000;129:21–
26.
25. Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N.
Clinicopathological correlation of polypoidal choroidal vasculopathy
revealed by ultrastructural study. Br J Ophthalmol 2002;86:1093–
1098
26. Ozawa S, Ishikawa K, Ito Y, Nishihara H, Yamakoshi T, Hatta
Y, Terasaki H. Differences in macular morphology between
polypoidal choroidal vasculopathy and exudative age-related macular
degeneration detected by optical coherence tomography. Retina
2009;29:793-802
27. Gross NE, Aizman A, Brucker A et al (2005) Nature and risk of
neovascularization in the fellow eye of patients with unilateral
retinal angiomatous proliferation. Retina 25:713–718
28. Yannuzzi LA, Negrao S, Iida T et al. Retinal angiomatous
proliferation in age-related macular degeneration. Retina
2001;21:416–434
References:
